These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1311943)

  • 1. Azoles, allylamines and drug metabolism.
    Back DJ; Tjia JF; Abel SM
    Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
    Back DJ; Tjia JF
    Br J Clin Pharmacol; 1991 Nov; 32(5):624-6. PubMed ID: 1659439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.
    Back DJ; Stevenson P; Tjia JF
    Br J Clin Pharmacol; 1989 Aug; 28(2):166-70. PubMed ID: 2775622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
    Barchiesi F; Falconi Di Francesco L; Scalise G
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origin of differences in susceptibility of Candida krusei to azole antifungal agents.
    Marichal P; Gorrens J; Coene MC; Le Jeune L; Vanden Bossche H
    Mycoses; 1995; 38(3-4):111-7. PubMed ID: 7477085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of retinoids and terbinafine on the human hepatic microsomal metabolism of cyclosporin.
    Shah IA; Whiting PH; Omar G; Ormerod AD; Burke MD
    Br J Dermatol; 1993 Oct; 129(4):395-8. PubMed ID: 8217751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
    Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
    Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
    Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.
    Rangel H; Dagger F; Hernandez A; Liendo A; Urbina JA
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2785-91. PubMed ID: 9124841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
    Abruzzo GK; Fromtling RA; Turnbull TA; Giltinan DM
    J Antimicrob Chemother; 1987 Jul; 20(1):61-8. PubMed ID: 3040658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro.
    Omar G; Whiting PH; Hawksworth GM; Humphrey MJ; Burke MD
    Ther Drug Monit; 1997 Aug; 19(4):436-45. PubMed ID: 9263386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new generation of antifungal drugs.
    Stevens DA
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):732-5. PubMed ID: 2850912
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole.
    Wang JS; Wen X; Backman JT; Taavitsainen P; Neuvonen PJ; Kivistö KT
    Pharmacol Toxicol; 1999 Oct; 85(4):157-61. PubMed ID: 10563513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.